FDA — Fidia SpA Share News
0.000.00%
Last trade - 00:00- €15.49m
- €19.02m
- €30.53m
Brief: Fidia Appoints Gianpiero Orlando CFO As Of Today
BioXcel plummets after FDA recommends additional trial for agitation treatment
Brief: Fidia Updates 2023-26 Industrial Plan, Lowers FY EBITDA Guidance To EUR 1.0 Mln
Brief: Fidia H1 Net Result Swings To Loss Of EUR 2.1 Mln
Taysha Gene down on plans to scrap rare pediatric disorder therapy program
Brief: Italy's Market Watchdog Approves Prospectus Supplement Related To Fidia's New Shares Trading Admission
Virios up on FDA's positive feedback on lead drug candidate
Incyte falls as FDA rejects extended-release version of lead drug
Brief: Fidia FY Net Result Swings To Profit Of EUR 6.0 Mln
Brief: Fidia Appoints Luigi Maniglio Executive Chairman
Brief: Italy's Market Watchdog Authorises Publication Of Prospect For Admission Of Trading Of Fidia's New Shares
Brief: Fidia Chairman, CEO Giuseppe Morfino Resigns
Brief: Fidia Sets Price Of Newly Issued Shares At 1.09 EUR/Shr
Brief: Fidia 2021 Net Loss Shrinks To EUR 3.2 Mln
Brief: Court In Ivrea, Italy, Authorises Creditors' Protection Agreement Proposed By Fidia
Brief: Fidia Says Majority Of 74.21% Of Credits Admitted To Vote Approves Arrangement With Its Creditors
Brief: Fidia FY Net Loss Widens To EUR 5.7 Mln
Brief: Fidia Appoints Secondo Dentis As Ad-Interim CFO
Brief: Court Of Ivrea Admits Fidia To Creditors' Protection Agreement Procedure In Business Continuity